Loading clinical trials...
Loading clinical trials...
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Conditions
Interventions
Vortioxetine 10 mg/day
Vortioxetine 20 mg/day
+2 more
Locations
124
United States
US1369
Dothan, Alabama, United States
US1333
Tucson, Arizona, United States
US1310
Little Rock, Arkansas, United States
US1062
Costa Mesa, California, United States
US1387
Downey, California, United States
US1114
Escondido, California, United States
Start Date
May 1, 2016
Primary Completion Date
July 2, 2019
Completion Date
July 30, 2019
Last Updated
August 19, 2020
NCT05415397
NCT07059234
NCT06396312
NCT06136546
NCT06398496
NCT06417619
Lead Sponsor
H. Lundbeck A/S
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions